Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar desktop iconMarkt Monitor

Aandeel Arrowhead Pharmaceuticals OTC:ARWR.Q, US04280A1007

Vertraagde koers (usd) Verschil Volume
21,050   +2,260   (+12,03%) Dagrange 20,847 - 24,230 8.052.165   Gem. (3M) 1,2M

GRTS (mRNA) Gritstone bio inc.

341 Posts
Pagina: «« 1 ... 13 14 15 16 17 18 | Laatste | Omlaag ↓
  1. forum rang 7 Ron Kerstens 18 oktober 2024 11:19
    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

    Trading of the Company’s common stock will be suspended at the opening of business on October 22, 2024 and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq.
341 Posts
Pagina: «« 1 ... 13 14 15 16 17 18 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.